ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.31
0.00%
US Tech 100
18,542.80
-0.27%
S&P 500
5,360.79
0.00%
US Dollar vs CAD
1.37733
0.08%
Bitcoin
66,944.28
-3.69%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. ARS Pharmaceuticals Inc (SPRY)

  7. ARS Pharmaceuticals Inc (SPRY) News

SPRY ARS Pharmaceuticals Inc

9.07
0.00 (0.00%)
Pre Market
Last Updated: 06:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
ARS Pharmaceuticals Inc SPRY NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.00 0.00% 9.07 06:00:00
Open Price Low Price High Price Close Price Previous Close
9.07
more quote information »

Recent News

Date Time Source Heading
5/16/202418:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/10/202406:01EDGAR2Form 8-K - Current report
5/09/202417:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/09/202415:08EDGAR2Form 8-K - Current report
5/09/202415:05GLOBEARS Pharmaceuticals Highlights neffy Regulatory Progress and..
4/30/202408:01GLOBEARS Pharmaceuticals Submits Response for neffy® (epinephrine..
4/03/202408:01GLOBEARS Pharmaceuticals Submits Response to FDA Complete..
3/21/202415:05GLOBEARS Pharmaceuticals Provides Business Update and Reports..
3/07/202415:05GLOBEARS Pharmaceuticals Reviews Recent Clinical Updates and..
3/07/202411:56EDGAR2Form 8-K - Current report
3/06/202408:01GLOBEARS Pharmaceuticals to Participate in the Leerink Partners..
3/01/202419:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/28/202420:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/26/202411:08EDGAR2Form 144 - Report of proposed sale of securities
2/26/202408:01GLOBEARS Pharmaceuticals announces neffy® meets primary endpoints..
2/22/202408:01GLOBEARS Pharmaceuticals to Host Virtual neffy® Investor Day on..
2/20/202408:01GLOBEARS Pharma Announces Favorable Topline Results from Repeat..
2/05/202408:01GLOBEARS Pharmaceuticals to Present Positive Clinical Efficacy..
1/04/202415:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/04/202415:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/04/202415:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/04/202415:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/09/202315:02EDGAR2Form 8-K - Current report
11/09/202315:00GLOBEARS Pharmaceuticals Reports Third Quarter 2023 Financial..
11/09/202310:02GLOBEARS Pharmaceuticals Announces Presentation of Clinical Data..
10/06/202308:57DJNARS Pharmaceuticals to Meet With FDA on Neffy Rejection
10/06/202308:03GLOBEARS Pharmaceuticals Announces Scheduling of a Type A Meeting..
10/03/202308:03GLOBESingle and Repeat Dose Clinical Study of neffy (epinephrine..
9/25/202315:17EDGAR2Form 8-K - Current report
9/20/202309:20DJNARS Pharmaceuticals Shares Sink to New Lows on FDA Neffy..
9/20/202305:30DJNARS Pharmaceuticals Shares Sink Premarket as FDA Rejects..
9/20/202305:05EDGAR2Form 8-K - Current report
9/19/202321:49GLOBEFDA Issues Complete Response Letter for neffy® (epinephrine..
9/01/202315:15EDGAR2Form SC 13D/A - General statement of acquisition of..
8/10/202315:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/10/202315:05EDGAR2Form 8-K - Current report
8/10/202315:00GLOBEARS Reports Second Quarter 2023 Financial Results and..
6/28/202320:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/28/202320:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/28/202315:32EDGAR2Form 8-K - Current report
6/20/202307:00GLOBEARS Pharmaceuticals Announces PDUFA Date Extension for..

Your Recent History

NASDAQ
SPRY
ARS Pharmaceuticals
ASX
MPGO
Many Peaks Gold
BIT
P1TEX5
NLBNPIT1TEX5 20240621 10
BIT
P1NPV8
BNP Paribas Issuance
USOTC
INPEF
Inspecs (PK)
BOV
CPLE3Q
COPEL ON
BIT
P13DF9
BNP Paribas Issuance
BIT
ALV
Allianz
MRTX
MBTCETH
Minibitcoin
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved